Nu Skin Enterprises, Inc. (NUS): R&D Expense
$10.80M
Year ended 2025-12-31
-22.6%
3-year compound annual growth
-14.3%
5-year compound annual growth
-6.0%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.80M | -16.9% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $13.00M | -42.5% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $22.60M | -3.0% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $23.30M | -14.3% | 2025-02-14, From 2022-01-01 |
| 2021-12-31 | $27.20M | +16.7% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $23.30M | -22.6% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $30.10M | +30.9% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $23.00M | +4.5% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $22.00M | -9.5% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $24.30M | +20.9% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $20.10M | +6.3% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $18.90M | +5.0% | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | $18.00M | +20.8% | 2016-02-18, From 2013-01-01 |
| 2012-12-31 | $14.90M | +9.6% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $13.60M | +9.7% | 2014-03-18, From 2011-01-01 |
| 2010-12-31 | $12.40M | +19.2% | 2013-02-27, From 2010-01-01 |
| 2009-12-31 | $10.40M | n/a | 2012-02-28, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Nu Skin Enterprises, Inc. (NUS) | 2025-12-31 | $10.80M | -16.9% |
| Cosmos Health Inc. (COSM) | 2025-12-31 | $519.4K | -2.6% |
| Stemtech Corp (STEK) | 2025-12-31 | $0 | n/a |
Compare NUS, COSM, STEK side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗